FSD Pharma Inc.
HUGE · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $570,637 | $2,742,107 | $2,354,334 | $3,084,063 |
| - Cash | $3,307 | $1,330 | $2,743 | $3,634 |
| + Debt | $625 | $624 | $337 | $363 |
| Enterprise Value | $567,955 | $2,741,401 | $2,351,929 | $3,080,791 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$120 | -$126 | -$145 |
| % Margin | – | – | – | – |
| EBITDA | -$3,207 | -$1,959 | -$1,529 | -$3,165 |
| % Margin | – | – | – | – |
| Net Income | -$3,112 | -$1,903 | -$1,697 | -$1,131 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.079 | -0.048 | -0.043 | -0.029 |
| % Growth | -63.5% | -11.4% | -49.1% | – |
| Operating Cash Flow | -$606 | -$1,965 | -$888 | -$1,713 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$606 | -$1,965 | -$888 | -$1,713 |